FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
Journal of Clinical Investigation (2011) - Comment
pubmed: 21436588  doi: 10.1172/jci44325  issn: 1558-8238  issn: 0021-9738 

Stephanie K. Watkins, Ziqiang Zhu, Elena Riboldi, Kim A. Shafer-Weaver, Katherine E.R. Stagliano, Martha M. Sklavos, Stefan Ambs, Hideo Yagita, Arthur A. Hurwitz